Weitere funktionelle Gefäßerkrankungen
- 15 April 2020
- book chapter
- Published by Springer Nature
- p. 1123-1125
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Effects of Tadalafil on Cold-induced Vasoconstriction in Patients with Raynaud's PhenomenonClinical Pharmacology & Therapeutics, 2007
- Phosphodiesterase Type 5 Inhibition Is a Novel Therapeutic Option in Raynaud DiseaseArchives of internal medicine (1960), 2006
- Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory TherapyCirculation, 2005
- Ergotism associated with HIV antiviral protease inhibitor therapyJournal of Vascular Surgery, 2003
- Systemic Sclerosis Therapy with Iloprost: A Prospective Observational Study of 30 Patients Treated for a Median of 3 YearsClinical Rheumatology, 2002
- Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialArthritis & Rheumatism, 1999
- Role of alpha‐adrenoceptor subtypes mediating sympathetic vasoconstriction in human digitsEuropean Journal of Clinical Investigation, 1988
- INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROMEThe Lancet, 1983
- Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)British Journal of Dermatology, 1982
- RAYNAUDʼS DISEASEThe American Journal of the Medical Sciences, 1932